V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210030606 | 210010860 | 1.74 | 29.9 | Disease modification (D) | 2017-10-18 | 2017-10-28 | Trial Unspecified | Y | N | 210027406 | TRIAL |
| 210030607 | 210021066 | 1.61 | 59.2 | Disease modification (D) | null | 2014-02-12 | Temozolomide + RT | 02 | N | 210027442 | TEMOZOLOMIDE + RT |
| 210030608 | 210010864 | 1.57 | 89.9 | Disease modification (D) | 2016-07-26 | 2016-08-23 | Temozolomide + RT | 02 | N | 210027462 | TEMOZOLOMIDE + RT |
| 210030609 | 210010865 | 1.75 | 27.1 | Unknown (U) | 2018-09-16 | 2019-02-25 | Trial Unspecified | N | N | 210027506 | TRIAL |
| 210030610 | 210010872 | 1.7 | 86.6 | Curative (C) | null | 2016-05-13 | Trial Unspecified | 1 | Y | 210027529 | TRIAL |
| 210030611 | 210010887 | null | 47.4 | Curative (C) | 2013-08-04 | 2013-08-04 | Trial Unspecified | null | null | 210027612 | TRIAL |
| 210030612 | 210010889 | null | 68.9 | Palliative (P) | 2016-05-11 | 2016-05-18 | Trial Unspecified | null | null | 210027613 | TRIAL |
| 210030613 | 210010890 | 1.89 | 123.9 | Disease modification (D) | 2017-08-03 | 2017-08-16 | Trial Unspecified | Y | N | 210027613 | TRIAL |
| 210030614 | 210038520 | 1.89 | 104.5 | Unknown (U) | 2013-07-21 | 2013-08-25 | Temozolomide + RT | 02 | N | 210027631 | TEMOZOLOMIDE + RT |
| 210030615 | 210010893 | 1.84 | 53 | Adjuvant (A) | 2015-08-01 | 2016-01-15 | Trial Unspecified | N | Y | 210027662 | TRIAL |
| 210030616 | 210010896 | 1.76 | 123.9 | Palliative (P) | 2016-08-06 | 2017-02-03 | Trial Unspecified | N | N | 210027684 | TRIAL |
| 210030617 | 210010899 | null | 121.6 | Curative (C) | 2018-04-19 | 2018-04-19 | Trial Unspecified | 01 | N | 210027688 | TRIAL |
| 210030618 | 210010900 | 1.51 | 53.4 | Curative (C) | null | 2016-11-29 | Temozolomide + RT | 02 | N | 210027718 | TEMOZOLOMIDE + RT |
| 210030619 | 210010902 | null | null | Disease modification (D) | 2014-01-24 | 2014-02-25 | Temozolomide + RT | null | null | 210027725 | TEMOZOLOMIDE + RT |
| 210030620 | 210010904 | 1.72 | 74.5 | Not known (9) | null | 2015-01-10 | Temozolomide + RT | N | N | 210027736 | TEMOZOLOMIDE + RT |
| 210030621 | 210021090 | null | 82.2 | Curative (C) | 2017-05-16 | 2017-07-25 | Temozolomide + RT | 02 | null | 210027745 | TEMOZOLOMIDE + RT |
| 210030622 | 210010910 | 1.74 | 67.6 | Curative (C) | null | 2015-05-30 | Temozolomide + RT | N | Y | 210027753 | TEMOZOLOMIDE + RT |
| 210030623 | 210010912 | 1.76 | 93.45 | Palliative (P) | 2013-09-17 | 2013-10-18 | Temozolomide + RT | 02 | N | 210027768 | TEMOZOLOMIDE + RT |
| 210030624 | 210010914 | null | 86.4 | Curative (C) | 2017-02-03 | 2017-07-27 | Trial Unspecified | Y | null | 210027779 | TRIAL |
| 210030625 | 210010914 | 1.63 | 86 | Curative (C) | 2017-08-10 | 2017-08-16 | Trial Unspecified | null | null | 210027779 | TRIAL |
| 210030626 | 210010919 | 1.63 | 79.8 | Palliative (P) | 2016-09-04 | 2016-09-15 | Trial Unspecified | null | N | 210027812 | TRIAL |
| 210030627 | 210010921 | 1.65 | 123.9 | null | 2014-08-05 | 2014-08-07 | CNS Medbl HR Cyclo+Vinc | null | null | 210027813 | TRIAL |
| 210030628 | 210010924 | null | 76 | null | 2013-11-27 | 2013-11-27 | Temozolomide + RT | N | null | 210027813 | TEMOZOLOMIDE + RT |
| 210030629 | 210034987 | 1.64 | null | Curative (C) | 2013-11-01 | 2013-11-01 | Trial Unspecified | Y | N | 210027828 | TRIAL |
| 210030630 | 210010925 | 1.72 | 60.9 | Palliative (P) | null | 2015-09-10 | Trial Unspecified | null | N | 210027835 | TRIAL |
| 210030631 | 210010930 | 1.82 | 108 | Adjuvant (A) | 2014-07-24 | 2014-09-24 | Rituximab | null | Y | 210027853 | RITUXIMAB |
| 210030632 | 210010934 | 1.65 | 51.8 | null | 2016-09-18 | 2016-10-09 | Rituximab | N | N | 210027862 | RITUXIMAB |
| 210030633 | 210010936 | 1.7 | null | Palliative (P) | 2015-07-29 | 2015-07-31 | IBRUTINIB | N | N | 210027866 | IBRUTINIB |
| 210030635 | 210010943 | 1.55 | 21.6 | Curative (C) | 2018-01-16 | 2018-01-16 | IBRUTINIB | N | N | 210027873 | IBRUTINIB |
| 210030636 | 210010945 | 1.55 | 47.8 | Palliative (P) | 2015-02-03 | 2015-03-16 | Rituximab (Maintenance) | 02 | N | 210027888 | RITUXIMAB |
| 210030637 | 210010947 | 1.79 | 225 | Palliative (P) | 2015-04-20 | 2015-04-20 | Lomustine | 2 | null | 210027892 | LOMUSTINE |
| 210030638 | 210010950 | 1.63 | 88.7 | Palliative (P) | null | 2018-02-25 | Rituximab | 02 | N | 210027899 | RITUXIMAB |
| 210030639 | 210010951 | 1.67 | 61.2 | Adjuvant (A) | 2018-04-27 | 2018-05-06 | IBRUTINIB | N | N | 210027909 | IBRUTINIB |
| 210030641 | 210021113 | null | 77.4 | Palliative (P) | 2018-04-07 | 2019-03-27 | IBRUTINIB | 02 | N | 210027925 | IBRUTINIB |
| 210030642 | 210021113 | 1.57 | null | Curative (C) | 2017-06-05 | 2017-10-31 | Rituximab | N | N | 210027925 | RITUXIMAB |
| 210030643 | 210010955 | 1.6 | 95.8 | Palliative (P) | 2015-05-16 | 2015-05-16 | Lomustine | 2 | N | 210027935 | LOMUSTINE |
| 210030644 | 210010957 | 1.54 | 47.3 | Palliative (P) | 2016-10-18 | 2016-10-18 | Lomustine | N | N | 210027941 | LOMUSTINE |
| 210030645 | 210010958 | null | 92.1 | Adjuvant (A) | 2016-07-31 | 2016-07-31 | IBRUTINIB | 02 | N | 210027944 | IBRUTINIB |
| 210030646 | 210010961 | null | 81 | Disease modification (D) | 2017-05-18 | 2017-07-10 | IBRUTINIB | 2 | N | 210027951 | IBRUTINIB |
| 210030647 | 210010964 | 1.69 | 60.6 | null | 2016-03-22 | 2016-03-24 | Rituximab | N | N | 210027956 | RITUXIMAB |
| 210030648 | 210010966 | 1.72 | 57.4 | Palliative (P) | 2014-03-16 | 2014-03-16 | Lomustine | N | Y | 210027956 | LOMUSTINE |
| 210030649 | 210010969 | 1.7 | 95.5 | null | 2018-11-10 | 2019-07-20 | IBRUTINIB | 02 | Y | 210027964 | IBRUTINIB |
| 210030650 | 210010972 | 1.59 | 56.8 | Palliative (P) | 2017-10-11 | 2017-10-11 | Lomustine | N | N | 210027966 | LOMUSTINE |
| 210030651 | 210010973 | 1.77 | 87 | null | 2013-11-02 | 2013-11-13 | Rituximab | N | N | 210027991 | RITUXIMAB |
| 210030652 | 210010975 | 1.67 | 101.9 | Palliative (P) | 2018-05-23 | 2018-11-21 | Lomustine | N | N | 210027993 | LOMUSTINE |
| 210030653 | 210010976 | 1.8 | 83.5 | Palliative (P) | 2018-07-11 | 2018-07-20 | IBRUTINIB | 2 | N | 210028000 | IBRUTINIB |
| 210030654 | 210010979 | 1.59 | 52 | Palliative (P) | 2017-05-27 | 2017-05-31 | IBRUTINIB | N | N | 210028008 | IBRUTINIB |
| 210030656 | 210010986 | 1.71 | 107.1 | Disease modification (D) | 2015-03-26 | 2015-04-17 | Lomustine | 2 | N | 210028016 | LOMUSTINE |
| 210030657 | 210010986 | 1.63 | 71.7 | Palliative (P) | 2017-04-17 | 2018-01-05 | Rituximab | N | N | 210028016 | RITUXIMAB |
| 210030658 | 210010988 | 1.65 | 82.6 | Disease modification (D) | 2015-08-29 | 2015-09-07 | IBRUTINIB | N | N | 210028028 | IBRUTINIB |